The therapeutic advances in cystic fibrosis transforming patients’ lives
'I used to treat sick patients with CF, now I treat healthier people with CF gene abnormalities', says Professor John Wilson
Many people diagnosed with CF are now reaching their 50s, 60s and beyond. It’s been a therapeutic revolution.
But the new generation of gene therapies such as ivacaftor and lumacaftor will not only help patients live longer, they are also improving quality of life.
Australian Doctor speaks with respiratory physician Professor John Wilson about the developments in management and treatment of this debilitating disorder.
We also hear from Nardia Robertson, now aged 50, about her life with cystic fibrosis.
